메뉴 건너뛰기




Volumn 29, Issue 4, 2000, Pages 419-420

Orlistat (Xenical) in the management of obesity

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; DEXFENFLURAMINE; FENFLURAMINE; FLUOXETINE; MAZINDOL; PHENTERMINE; SEROTONIN AGONIST; TETRAHYDROLIPSTATIN;

EID: 0033777092     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (5)

References (11)
  • 1
    • 0001573227 scopus 로고
    • Obesity
    • Isselbacher K J, et al, editors. Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill
    • (1994) , pp. 446-452
    • Olefsky, J.M.1
  • 2
    • 0002403332 scopus 로고
    • Eating disorders: Obesity, anorexic nervosa, and bulimia nervosa
    • Wilson J D, Foster D W, editors. Williams Textbook of Endocrinology. 8th ed. Philadelphia: Saunders
    • (1992) , pp. 1335-1366
    • Foster, D.W.1
  • 5
    • 85173303768 scopus 로고    scopus 로고
    • National Health Survey 1998, Singapore. Singapore: Ministry of Health
    • (1999) , pp. 24
  • 6
    • 85173349547 scopus 로고    scopus 로고
    • Obesity: Complications, management and prevention
    • Johan B A, editor. Proc Seminar on Cardiovascular Rehabilitation, National Heart Centre
    • (2000) , pp. 5-11
    • Cheah, J.S.1
  • 10
    • 0032408205 scopus 로고    scopus 로고
    • Treatment with Orlistat reduces cardiovascular risk in obese patients
    • (1998) J Hypertens , vol.16 , pp. 2013-2017
    • Zavoral, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.